Research
A study released in October 2006 shows an increased risk of heart attacks in people with psoriasis. The risk was highest in young patients with severe psoriasis.
Drug Research
Results from a Phase III (late-stage) study show that adalimumab (Humira) is more effective than methotrexate in the treatment of moderate-to-severe psoriasis. In the study, 80% of patients treated for 16 weeks with adalimumab reported a 75% or better improvement, compared with 36% of patients treated with ...
Read more »My name is Seth Ginsberg, originally from Rockland County, a suburb of New York City, and now a New... Read more »
(Ivanhoe Newswire) -- Pediatricians now have a new tool to ensure nearly every child can be safely vaccinated against deadly diseases, including... Read summary »
SIMI VALLEY, Calif. (Ivanhoe Broadcast News) -- In the middle of a California desert, doctors perform a revolutionary surgical procedure. The... Read summary »
By Rebekah Addy, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- People in pain often reach for a common painkiller like... Read summary »
(Ivanhoe Newswire) -- Some doctors are calling for people to have more control over their own heart health by allowing statins, medications now... Read summary »
(Ivanhoe Newswire) -- A new study reveals it is generally safe to stop anti-seizure medications in children with epilepsy who have been seizure-free... Read summary »